Acute eosinophilic pneumonia and illicit psychoactive substance use

被引:3
|
作者
Underner, M. [1 ]
Perriot, J. [2 ]
Peiffer, G. [3 ]
Urban, T. [4 ]
Jaafari, N. [1 ]
机构
[1] Univ Poitiers, Ctr Hosp Henri Laborit, Unite Rech Clin, F-86021 Poitiers, France
[2] Dispensaire Emile Roux, Ctr Tabacol, F-63100 Clermont Ferrand, France
[3] CHR Metz Thionville, Serv Pneumol, F-57038 Metz, France
[4] CHU Angers, Serv Pneumol, 4 Rue Larrey, F-49933 Angers, France
关键词
Acute easinoptiilic pneumonia; Cannabis; Cocaine; Heroin; Amphetamine; BRONCHOALVEOLAR LAVAGE FLUID; CIGARETTE-SMOKING; PULMONARY COMPLICATIONS; CRACK COCAINE; CANNABIS USE; LUNG; IL-5;
D O I
10.1016/j.rmr.2019.07.010
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Illicit psychoactive substance (IPAS) use can lead to a number of respiratory complications, including acute eosinophilic pneumonia (AEP). Systematic literature review of data on AEP in IPAS users (cannabis, cocaine, heroin and amphetamine). Of two cases of cannabis and tobacco users reported to have developed AEP, one, a teenage15 year old boy presented with acute respiratory distress syndrome (ARSD) which necessitated extracorporeal membrane oxygenation (ECMO). Five cases of AEP in cocaine smokers (crack) are reported, one of which was fatal. The patient presented with acute pulmonary edema and ARDS which progressed to ventricular fibrillation and asystole. 424-year-old woman presented with AEP after repeated inhalation of heroin. Finally, a case of an amphetamine abuser who developed AEP and ARDS after amphetamine inhalation is reported. The time between the first IPAS use and admission in cases reported ranged from 7 days to 4 years, white time between the last IPAS use and admission was short (less than 15 days). IPAS use must be sought in case of AEP, especially in young adults, and practitioners must advise and help users to stop their consumption. (C) 2019 SPLF. Published by Elsevier Masson SAS. All rights reserved.
引用
下载
收藏
页码:34 / 44
页数:11
相关论文
共 50 条
  • [41] NOT YOUR TYPICAL PNEUMONIA: A CASE OF ACUTE EOSINOPHILIC PNEUMONIA
    Saxena, Ankita
    Jasti, Harish
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 : S574 - S574
  • [42] ETIOLOGY OF PSYCHOACTIVE SUBSTANCE USE - FAZEY,C
    PLANT, M
    BRITISH JOURNAL OF ADDICTION, 1978, 73 (03): : 328 - 328
  • [43] PSYCHOACTIVE SUBSTANCE USE DISORDER IN YOUTH SUICIDE
    RUNESON, B
    ALCOHOL AND ALCOHOLISM, 1990, 25 (05): : 561 - 568
  • [44] PSYCHOACTIVE SUBSTANCE USE - SOME ASSOCIATED CHARACTERISTICS
    ARDILA, A
    BATEMAN, JR
    ADDICTIVE BEHAVIORS, 1995, 20 (04) : 549 - 554
  • [45] Acute Eosinophilic Pneumonia Secondary to Daptomycin
    Somoza-Cano, Francisco J.
    Makadia, Austin
    Cruz-Peralta, Massiel P.
    Zakarna, Lara
    Demyda, Eleonora
    Al Armashi, Abdul Rahman
    Patell, Kanchi
    Altaqi, Basel
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (11)
  • [46] Acute eosinophilic pneumonia associated with tenidap
    Martinez, BM
    Domingo, P
    BRITISH MEDICAL JOURNAL, 1997, 314 (7077): : 349 - 349
  • [47] Acute eosinophilic pneumonia secondary to daptomycin
    Montenegro, Omar
    del Campo, Rafael
    Jose del Rio, Juan
    Ambros Checa, Alfonso
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2016, 34 (06): : 390 - 391
  • [48] Acute eosinophilic pneumonia associated to sertraline
    Haro, M
    Rubio, M
    Xifré, B
    Castro, P
    MEDICINA CLINICA, 2002, 119 (16): : 637 - 638
  • [49] FLUCLOXACILLIN INDUCED ACUTE EOSINOPHILIC PNEUMONIA
    Siu, Johnny Hong Chun
    Hsu, Kelvin
    Frankel, Anthony
    RESPIROLOGY, 2019, 24 : 4 - 5
  • [50] ACUTE EOSINOPHILIC PNEUMONIA WITH FATAL OUTCOME
    NOIROT, A
    FLORIOT, C
    BOUDON, B
    DELACOUR, JL
    WAGSCHAL, G
    DAOUDAL, P
    PRESSE MEDICALE, 1990, 19 (19): : 920 - 920